Legend Biotech (LEGN) Tops Q1 EPS by 3c

Legend Biotech (NASDAQ: LEGN) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $93.99 million versus the consensus estimate of $143.81 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• Colony Bankcorp to acquire First Reliance in $163M stock-and-cash deal
• Qualcomm expects $40bn in non-handset revenue by fiscal 2029